Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuaibing Liu

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Frontiers in Public Health|October 30, 2023
Designing a doctor evaluation index system for an online medical platform based on the information system success model in ChinaShuaibing Liu, Yunqiu Zhang
Clinical Pharmacology and Therapeutics|March 2, 2024
Physiologically Based Pharmacokinetic Modeling to Investigate the Disease-Drug-Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID-19 Patients with CYP2C19 PhenotypesPeile Wang, Shuaibing Liu, Jing Yang
Pharmaceutical Research|March 28, 2020
Challenging the Relevance of Unbound Tissue-to-Blood Partition Coefficient (Kp<sub>uu</sub>) on Prediction of Drug-Drug InteractionsJasleen K Sodhi, Shuaibing Liu, Leslie Z Benet
Frontiers in Pharmacology|January 11, 2021
Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling ApproachShuaibing Liu, Ziteng Wang, Xin Tian, et al.
Pharmaceutical Research|November 3, 2021
Analyzing Potential Intestinal Transporter Drug-Drug Interactions: Reevaluating Ticagrelor Interaction StudiesShuaibing Liu, Jasleen K Sodhi, Leslie Z Benet
Frontiers in Pharmacology|May 3, 2021
Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling ApproachShuaibing Liu, Ziteng Wang, Xin Tian, et al.
Pharmaceutical Research|September 30, 2020
Intestinal Efflux Transporters P-gp and BCRP Are Not Clinically Relevant in Apixaban DispositionJasleen K Sodhi, Shuaibing Liu, Leslie Z Benet
Journal of Chromatographic Science|February 26, 2021
A Validated LC-MS/MS Method for the Simultaneous Determination of Ticagrelor, Its Two Metabolites and Major Constituents of Tea Polyphenols in Rat Plasma and Its Application in a Pharmacokinetic StudyYing Xue, Ziteng Wang, Weimin Cai, et al.
Frontiers in Oncology|September 2, 2024
Hepatic perivascular epithelioid cell tumor: a retrospective analysis of 36 casesMin Ji, Yuchen Zhang, Shuaibing Liu, et al.
Biomed Research International|July 24, 2013
Application of improved three-dimensional kernel approach to prediction of protein structural classXu Liu, Yuchao Zhang, Hua Yang, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Public Health|October 30, 2023
Designing a doctor evaluation index system for an online medical platform based on the information system success model in ChinaShuaibing Liu, Yunqiu Zhang
Clinical Pharmacology and Therapeutics|March 2, 2024
Physiologically Based Pharmacokinetic Modeling to Investigate the Disease-Drug-Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID-19 Patients with CYP2C19 PhenotypesPeile Wang, Shuaibing Liu, Jing Yang
Pharmaceutical Research|March 28, 2020
Challenging the Relevance of Unbound Tissue-to-Blood Partition Coefficient (Kp<sub>uu</sub>) on Prediction of Drug-Drug InteractionsJasleen K Sodhi, Shuaibing Liu, Leslie Z Benet
Frontiers in Pharmacology|January 11, 2021
Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling ApproachShuaibing Liu, Ziteng Wang, Xin Tian, et al.
Pharmaceutical Research|November 3, 2021
Analyzing Potential Intestinal Transporter Drug-Drug Interactions: Reevaluating Ticagrelor Interaction StudiesShuaibing Liu, Jasleen K Sodhi, Leslie Z Benet
Frontiers in Pharmacology|May 3, 2021
Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling ApproachShuaibing Liu, Ziteng Wang, Xin Tian, et al.
Pharmaceutical Research|September 30, 2020
Intestinal Efflux Transporters P-gp and BCRP Are Not Clinically Relevant in Apixaban DispositionJasleen K Sodhi, Shuaibing Liu, Leslie Z Benet
Journal of Chromatographic Science|February 26, 2021
A Validated LC-MS/MS Method for the Simultaneous Determination of Ticagrelor, Its Two Metabolites and Major Constituents of Tea Polyphenols in Rat Plasma and Its Application in a Pharmacokinetic StudyYing Xue, Ziteng Wang, Weimin Cai, et al.
Frontiers in Oncology|September 2, 2024
Hepatic perivascular epithelioid cell tumor: a retrospective analysis of 36 casesMin Ji, Yuchen Zhang, Shuaibing Liu, et al.
Biomed Research International|July 24, 2013
Application of improved three-dimensional kernel approach to prediction of protein structural classXu Liu, Yuchao Zhang, Hua Yang, et al.
Pageof 5